Results 161 to 170 of about 90,799,159 (308)

Household’s willingness to pay for safe drinking water: A case study of Abbottabad district [PDF]

This study is based on survey data and used both the contingent valuation method and averting behaviour approach to capture HH's willingness to pay for services and quality in the drinking water sector. In case of the HH’s WTP for improved water services,
Ahmad, Iftikhar, Usman Mustafa, Usman, Haq, Mirajul   +2 more
core  

Can immersive virtual reality be an alternative world for eliciting consumer willingness to pay for food? [PDF]

PLoS One
Nakajima T, Mukai M.
europepmc   +1 more source

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

British Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić, Ivana Stević, Elvira Meni Maria Gkrinia, Dinko Vitezić, Slobodan Janković   +4 more
wiley   +1 more source

Willingness to Pay for Drinking Water and Sanitation Availability in Indonesia [PDF]

When sustainability of access and quality, is the primary concern, water and saniatioan should be considered as economic goods. Therefore, we need more accurate information on the amount of people’s willingness to pay.
Bilang Nauli Harahap, Djoni Hartono
core  

Public Willingness to Pay for Alzheimer's Preventive Medication in Iran: A Contingent Valuation Study. [PDF]

Risk Manag Healthc Policy
Soofi M, Amiri F, Rezaei S, Ahmadi S.
europepmc   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Testing sensitivity of willingness to pay for mortality risk reduction [PDF]

Contingent valuation method was used in this study to elicit willingness to pay for risk reduction of dying because of cardiovascular or respiratory diseases.
Marek Giergiczny
core  

Artificial intelligence in Vietnamese healthcare: public awareness, demand, and willingness to pay. [PDF]

BMC Health Serv Res
Thi TN, Hoang TN, Hanh HD, Hoang LN.
europepmc   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source

Cost‐effectiveness of DPYD genotyping prior to fluoropyrimidine‐based treatment for colorectal cancer in Wales

British Journal of Clinical Pharmacology, EarlyView.
Abstract Background Regulatory guidance in the United Kingdom advises DPYD genotyping prior to fluoropyrimidine‐based treatment. This economic evaluation estimated the costs and outcomes associated with DPYD screening prior to prescribing fluoropyrimidines for colorectal cancer in Wales and also considers additional variants to those included in ...
Catrin O. Plumpton, Sian M. Morgan, Richard A. Adams, Samantha Cox, Angharad A. Rudkin, Megan Fealey, Craig Barrington, Michelle D. Wood, Dyfrig A. Hughes   +8 more
wiley   +1 more source